Tax credit pushes hospitals to switch to cleaner anesthetic gases

What it does

This bill creates a federal tax credit for hospitals and surgical centers that switch from high-emission anesthetic gases (desflurane and nitrous oxide) to lower-emission alternatives (isoflurane or sevoflurane). The credit ranges from 15% to 50% of the cost of purchasing these gases, depending on how much the facility reduces its emissions year-over-year, plus up to $1,500 per mobile anesthetic machine retrofitted to use the cleaner gases. The credit expires December 31, 2029.

Why we flagged it

The bill's operative mechanism is a tax credit tied to measurable environmental performance (emission reduction), not a subsidy or carve-out. It uses market incentives (tax relief) to drive behavior change toward a public environmental goal.

What the text implies

• Credit benefits facilities with capital to retrofit equipment; smaller or under-resourced hospitals may lack funds to switch gases and thus cannot claim the credit, potentially widening disparities in environmental compliance across healthcare systems.
• The credit is elective (facilities can choose to claim it or not), meaning uptake depends on administrative capacity and tax sophistication; some eligible facilities may not benefit simply because they lack tax-planning resources.
• Anesthetic-gas emissions are a small fraction of healthcare's total carbon footprint; this credit does not address larger sources like energy use, transportation, or supply-chain emissions, potentially creating a false sense of climate action.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill incentivizes a measurable reduction in greenhouse-gas emissions from a specific medical source without restricting patient access to anesthesia or raising healthcare costs. Patients and communities benefit from lower climate impact; the credit is time-limited and tied to actual emission reductions, not a permanent subsidy.

Who stands to gain

• hospitals and ambulatory surgical centers (via tax credits)
• manufacturers of isoflurane and sevoflurane (increased demand)
• equipment retrofitting contractors

Named in the bill

Internal Revenue Code of 1986, Section 45BB (new tax credit), Section 38 (general business credit), Section 6417 (elective payment of credits), isoflurane, sevoflurane, desflurane, nitrous oxide, health care facilities, hospitals, ambulatory surgical centers, Secretary of the Treasury — and 2 more

Where it stands

• Oct 9, 2026 — Introduced · Congress.gov: “Introduced in House”
• Oct 9, 2026 — Referred to House Committee on Ways and Means · Congress.gov: “Referred to the House Committee on Ways and Means”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.